As outlined in earlier post February is going to be the turning...

As outlined in earlier post February is going to be the turning point for JAT.
- Shanghai retail store opens
- Online retail store launch
- Launch of Abbeyard A2 Protein (competing product to A2M)
- 1,000 Wumart stores commence selling JAT products

The additional revenue to be generated from these is substantial. At a minimum we expect:-
Q1/21 growth 100% (partial sales from above)
Q2/21 growth to be 100%+ (all new revenue streams online)

The earnings potential of JAT's retail plan in China is enormous. JAT is opening the first of multiple retail outlets in China and not only that, will sell Abbeyard A2 to compete with A2M. The only ASX listed infant milk company with local stores. Whilst the other infant milk formula companies rely on Daigou resellers who are restricted with travel conditions, JAT will stock local shelves in China. This will see substantially increased sales, lowered costs and better margins.

China births over 17M babies a year. The infant milk formula you see the Daigou buying in hoards in Australia lands in China at 300% the price and the people are happy to pay for it. Can you imagine the margin and price JAT will be able to play with selling direct into China retail an A2 Protein milk formula?

We will have another big update on JAT over the weekend to produce. All based from JAT's own announcements. Some of our members are locals in Shanghai and are going to get photos of the store.

For now we will say, 'stay tuned'.